• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Advocating for Yourself or Loved Ones When Bladder Cancer is Suspected

By: StatePoint Media
December 12, 2023 at 01:00 AM EST

photo

SPONSORED CONTENT -- (StatePoint) If you or someone you know may have bladder cancer, being well informed could get you the best diagnosis and treatment. In fact, according to an article published in “Urologic Oncology,” in 46.5% of the cases where a bladder was removed because of advanced cancer, a very serious type of tumor called carcinoma in situ (CIS) had been missed in past transurethral resection of bladder tumor (TURBT) procedures. This alarming statistic magnifies the need for urologists to have enhanced tumor visibility during TURBTs. There is one procedure that can offer visibility of hard-to-see tumors including CIS; it’s called Blue Light Cystoscopy (BLC). Here’s what to know:

TURBT can be a critical diagnostic step when done properly and precisely. The TURBT provides essential information regarding the number of tumors, tumor sizes, locations and depth of invasion. All these factors significantly inform the identification of a patient’s risk category, which can subsequently impact treatment decisions.

Currently, White Light Cystoscopy is most commonly used for a patient’s first TURBT and is considered the standard level of care. However, research suggests that using White Light Cystoscopy alone may be inadequate, causing:

• Incomplete tumor resection: After one year, there is a rate of up to 61% of non-muscle invasive bladder cancer recurrence, suggesting incomplete tumor resection when using only White Light Cystoscopy.

• New tumor growth: Up to 70% of patients have tumors recur after standard TURBT.

• Tumors found during subsequent TURBT procedures: Up to 86% of residual tumors are found at the original resection site after initial white-light TURBT.

So, how can patients ensure better diagnostics and treatment? Experts say that asking for BLC during the first TURBT is a great way to advocate for yourself or a loved one. BLC is a technology that allows urologists to see tumors that white light alone may miss. Unfortunately, it is not always utilized at the first encounter with the patient.

Suzanne B. Merrill, MD, FACS, Colorado Urology said, “By using Blue Light Cystoscopy for first TURBT, urologists can more completely assess the bladder, achieve greater tumor eradication and provide more data for appropriate diagnosis. Doing the procedure with enhanced visibility right at the start of patient care can better establish the appropriate treatment regimen for each patient and lower the risk of disease recurrence.”

Dr. Merrill recommends that patients and their loved ones be their own advocates when it comes to their diagnosis.

Need some tips for how to talk to your urologist about TURBT and BLC? Follow these steps:

1. Find a trusted urologist in your area.

2. Inquire about BLC with your urologist.

3. Explain to your urologist that you’re interested in BLC at your first TURBT to ensure better tumor visibility.

4. If your urologist does not offer BLC, find one that does.

To find locations that offer BLC, visit https://rebrand.ly/BLC-Locations.

“When it comes to your medical care, you should always feel comfortable advocating for yourself,” says Dr. Merrill. “You may need to speak to more than one urologist, but doing so can mean better outcomes for your health in the long term.”

This article is sponsored by Photocure, Inc.

*****

More News

View More
FICO’s Big Dip Could Be the Best Buying Chance of the Year
Today 18:42 EDT
Via MarketBeat
Tickers EFX FICO
D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
Today 17:38 EDT
Via MarketBeat
Tickers QBTS RGTI
Datavault: A Speculative AI Play, But Beware of Volatility
Today 16:42 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers DVLT IBM SCLX
Traders Are Piling Into Suncor Call Options—Should You?
Today 14:28 EDT
Via MarketBeat
Topics World Trade
Tickers SU
Delta Air Lines Stock Looks Ready to Fly to New Highs
Today 13:44 EDT
Via MarketBeat
Tickers DAL
Recent Quotes
View More
Symbol Price Change (%)
GOOG  244.64
+7.15 (3.01%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap